ArticleAIDS and behavior2025
Effect of Depression on Quality of Life among Women Living with HIV in Gondar Town, Northwest, Ethiopia, Prospective Cohort Study.
Article in AIDS and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Depression is highly prevalent among women living with HIV (WLHIV) and is linked to poor quality of life (QoL), impaired functioning, and negative treatment outcomes. While studies in high-income settings report strong associations between depression, stigma, social support, and QoL, evidence from low-resource contexts such as Ethiopia remains limited. This study examined the relationship between depression and QoL among 627 WLHIV on stable antiretroviral therapy (ART) for at least six months. Data were collected prospectively at three-month intervals between September 2023 and April 2024 using structured interviews. Validated tools assessed depression (PHQ-9), HIV-related stigma, social support (Oslo scale), and QoL (WHOQOL-HIV BREF-Eth-27). Repeated measures ANOVA and linear mixed-effects models evaluated QoL trajectories and the impact of depression while adjusting for confounders. Depression was significantly associated with lower scores across all QoL domains: general (β = -0.06, p = 0.000), physical (β = -0.22, p = 0.000), psychological (β = -0.25, p=), spiritual (β = -0.08, p = 0.000), independence (β = -0.13, p = 0.000), environmental (β = -0.23, p = 0.000), and social (β = -0.09, p = 0.000). Non-adherence to ART also negatively affected multiple domains, including general (β = -0.28, p = 0.035), physical (β = -0.51, p = 0.031), psychological (β = -0.72, p = 0.003), social (β = -0.50, p = 0.006), and environmental (β = -0.97, p = 0.015). HIV-related stigma reduced QoL in six domains, while greater social support was positively associated with all domains. These findings underscore the urgent need to address depression, stigma, and ART adherence while promoting social support to improve QoL among WLHIV in Ethiopia.
Indexed as
Identifiers
40551072What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.